Resultados de búsqueda - Xiaomin Wan
- Mostrando 1 - 4 Resultados de 4
-
1
First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost‐effectiveness analysis... por Xiaomin Wan, Xia Luo, Chongqing Tan, Xiaohui Zeng, Yucong Zhang, Liubao Peng
Publicado 2019Artigo -
2
-
3
-
4
Cost-Effectiveness of First-Line Versus Second-Line Pembrolizumab or Chemotherapy in Patients With Microsatellite-Instability-High/Mismatch Repair-Deficient Advanced Colorectal Can... por Chongqing, Tan, Sini, Li, Xiaohui, Zeng, Liubao, Peng, Ye, Peng, Shuxia, Qin, Liting, Wang, Meiyu, Wu, Xiaomin, Wan
Publicado 2021Texto
Herramientas de búsqueda:
Materias Relacionadas
Cancer
Immunotherapy
Internal medicine
Lung cancer
Medicine
Oncology
Alternative oxidase
Arabidopsis
Arabidopsis thaliana
Atezolizumab
Bevacizumab
Biochemistry
Biology
Carboplatin
Cell biology
Cellular respiration
Chemotherapy
Cisplatin
Cost effectiveness
Cytosol
Docetaxel
Enzyme
Gene
Intensive care medicine
Mitochondrion
Mutant
Nivolumab
Organelle
Paclitaxel
Pembrolizumab